Literature DB >> 10906517

Treatment of otitis media with effusion in children with mucopolysaccharidoses.

M Motamed1, S Thorne, A Narula.   

Abstract

Otitis media with effusion (OME) is a constant finding in children with mucopolysaccharidoses (MPS). Affected children may also present the anaesthetist with a difficult airway. A 7-year retrospective review of the management of OME in individuals with MPS was carried out. Nine patients were identified. All had a number of short-term ventilation tube insertions (one to four, mean two) before a diagnosis of MPS was made. Following diagnosis three required repeated short-term ventilation tubes insertions (two to four, mean three), four had long-term ventilation tube insertions once only. Five children who had residual hearing loss were provided with hearing aids but compliance was poor in two. Once a diagnosis of MPS has been made, a hearing aid, if compliant, or a long-term ventilation tube would be a better option than a short term one in order to minimise the anaesthetic risk. A 'watch and wait' policy is not recommended.

Entities:  

Mesh:

Year:  2000        PMID: 10906517     DOI: 10.1016/s0165-5876(00)00320-7

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  7 in total

1.  Hearing loss in patients with mucopolysaccharidosis II: data from HOS - the Hunter Outcome Survey.

Authors:  Annerose Keilmann; Todsaporn Nakarat; Iain A Bruce; David Molter; Gunilla Malm
Journal:  J Inherit Metab Dis       Date:  2011-08-25       Impact factor: 4.982

2.  Age-related functional and histopathological changes of the ear in the MPS I mouse.

Authors:  Patricia A Schachern; Sebahattin Cureoglu; Vladimir Tsuprun; Michael M Paparella; Chester B Whitley
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2006-11-13       Impact factor: 1.675

Review 3.  ENT and mucopolysaccharidoses.

Authors:  Pier Marco Bianchi; Renato Gaini; Silvano Vitale
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

4.  Neurophysiology of hearing in patients with mucopolysaccharidosis type IV.

Authors:  Kyoko Nagao; Thierry Morlet; Elizabeth Haley; Jennifer Padilla; Julianne Nemith; Robert W Mason; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2018-02-08       Impact factor: 4.204

5.  Management of otolaryngological manifestations in mucopolysaccharidoses: our experience.

Authors:  M Mesolella; M Cimmino; E Cantone; A Marino; M Cozzolino; R Della Casa; G Parenti; M Iengo
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-08       Impact factor: 2.124

Review 6.  Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.

Authors:  Christiane S Hampe; Julie B Eisengart; Troy C Lund; Paul J Orchard; Monika Swietlicka; Jacob Wesley; R Scott McIvor
Journal:  Cells       Date:  2020-08-05       Impact factor: 6.600

7.  Otorhinolaryngological Management in Taiwanese Patients with Mucopolysaccharidoses.

Authors:  Chung-Lin Lee; Kuo-Sheng Lee; Chih-Kuang Chuang; Chin-Hui Su; Huei-Ching Chiu; Ru-Yi Tu; Yun-Ting Lo; Ya-Hui Chang; Hsiang-Yu Lin; Shuan-Pei Lin
Journal:  Int J Med Sci       Date:  2021-07-25       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.